See What HealthDay Can Do For You
Contact Us

Clinical Trials Update: April 15 2005

COPD (Chronic Obstructive Pulmonary Disease) Generalized Anxiety Disorder (GAD) Metabolic Syndrome

(HealthDay News) -- Here are the latest clinical trials, courtesy of CenterWatch:

COPD (Chronic Obstructive Pulmonary Disease)

Qualified participants for this study must be at least 40 years old. They will receive study-related care and study medication, plus compensation for time and travel. Research site located in West Palm Beach, Fla.

More Information

Please see http://www.centerwatch.com/patient/studies/cat44.html.

-----

Generalized Anxiety Disorder (GAD)

The purpose of this study is to research different doses of an investigational drug in approximately 350 patients, between the ages 18-65 years old that have a doctor's diagnosis of generalized anxiety disorder. Research sites located throughout the United States.

More Information

Please see http://www.centerwatch.com/patient/studies/cat414.html.

-----

Metabolic Syndrome

People with the metabolic syndrome (MeS) are at increased risk of developing cardiovascular disease. This increased risk may, in part, be related to abnormalities in the blood vessels. Research site located in Baltimore, MD.

More Information

Please see http://www.centerwatch.com/patient/studies/cat556.html.

-----

Copyright 2005 CenterWatch. All rights reserved.

Consumer News

HealthDay

HealthDay is the world’s largest syndicator of health news and content, and providers of custom health/medical content.

Consumer Health News

A health news feed, reviewing the latest and most topical health stories.

Professional News

A news feed for Health Care Professionals (HCPs), reviewing latest medical research and approvals.